PCI and Penn Medicine partnered with Citizens JMP for the inaugural ‘Novel Therapeutics Forum’ at Penn. The Forum brought together innovative Penn faculty and regional startups to present before an audience of national investors seeking to learn more about Philadelphia’s biotech innovators. Faculty and startups participating included Sara Cherry, PhD, John W. Eckman Professor of Medical Science, Department of Pathology and Laboratory Medicine; Norbert Pardi, PhD, Assistant Professor of Microbiology; Jennifer Phillips-Cremins, PhD, Associate Professor of Genetics, Perelman School of Medicine & Associate Professor of Bioengineering, School of Engineering and Applied Sciences; Benjamin Prosser, PhD, Associate Professor of Physiology; Saar Gill, MD, PhD, Associate Professor of Medicine and co-founder, Carisma Therapeutics Inc. & Interius BioTherapeutics, Inc.; and Opus Genetics among others.
Securing investment capital to the Philadelphia region from new sources represents a critical component in building the burgeoning our local life sciences industry and PCI was gratified to help support this inaugural effort.